Nac Akut Ratiopharm (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac Akut, is a mucolytic presented as a pharmaceutical product for buccal, cutaneous and oral use. It helps to thin respiratory secretions and is also used in the management of acetaminophen overdose in appropriate clinical settings.

GNH USA supplies Nac Akut as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine acts as a mucolytic and antidote across several respiratory and toxicological pathways.

- Chronic bronchitis: reduces mucus viscosity, facilitating expectoration and improving airflow. - Chronic obstructive pulmonary disease (COPD): assists in clearing airway secretions, supporting respiratory function. - Acetaminophen (paracetamol) overdose: replenishes glutathione stores, helping to detoxify the toxic metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI).

Acetylcysteine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea or vomiting - Diarrhea or abdominal discomfort - Skin rash or mild itching - Unpleasant odor on breath or urine - Metallic taste in the mouth - Headache

Serious or Rare Side Effects: - Anaphylactoid reactions (e.g., bronchospasm, hypotension) - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic enzyme elevations in susceptible individuals - Acute respiratory distress in high‑dose intravenous administration - Hemolysis in patients with glucose‑6‑phosphate dehydrogenase deficiency

Before using Acetylcysteine, consider the following safety measures.

- Assess renal function: dose adjustment may be required in severe impairment. - Monitor for hypersensitivity: discontinue if anaphylactoid symptoms appear. - Evaluate hepatic status: use cautiously in patients with active liver disease. - Pregnancy and lactation: only use if the potential benefit outweighs risk, after professional assessment. - Concomitant medications: review for possible interactions, especially with nitroglycerin or anticoagulants. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Acetylcysteine can influence the activity of several co‑administered drugs.

Major Interactions (Avoid): - Nitroglycerin: may potentiate hypotensive effects. - Activated charcoal: can reduce oral absorption of acetylcysteine.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, requiring INR monitoring. - Certain antibiotics (e.g., carbapenems): may increase risk of rash. - Chemotherapeutic agents: potential for altered oxidative stress response. - Inhaled bronchodilators: monitor for additive bronchospasm risk. - Diuretics: watch for electrolyte disturbances when combined with high‑dose IV therapy.